January 8, 2024 News by Marisa Wexler, MS In MS, spinal cord atrophy, chronic inflammation predict progression In people with multiple sclerosis (MS), disability worsening independent of relapse activity ā commonly known as “silent progression” ā tends to be accompanied by greater atrophy, or shrinkage, in the spinal cord, as well as a higher number of lesions with chronic inflammation, known as paramagnetic rim lesions or…
July 25, 2022 Columns by Ed Tobias MS News That Caught My Eye Last Week: Intermittent Fasting, Roe v. Wade, IRLs Intermittent Fasting in MS Leads to Immune Cell, Metabolic Changes Although the National MS Society will tell you there is no such thing as an “MS diet,” many people follow various diets that seem to help them. One that’s been around for several years is intermittent fasting. In…
January 3, 2022 Columns by Ed Tobias MS News That Caught My Eye Last Week: Cortrophin Gel, Simvastatin, COVID-19 Treatments Cortrophin Gel Now Available in US at AllianceRx Walgreens Prime Cortrophin Gel is similar to Achtar Gel, which was, until the U.S. Food and Drug Administration’s recent re-approval of Cortrophin, the only repository corticotropin injection available in the U.S. Cortrophin Gel is a naturally produced cortisol that is expected…
September 20, 2021 Columns by Ed Tobias MS News That Caught My Eye Last Week: COVID-19 Vaccines, Bladder and Bowel Problems, Rim Lesions Patients on Anti-CD20 Therapies Urged to Get COVID-19 Vaccine Some people being treated with disease-modifying therapies (DMTs) that reduce their CD20 B-cells have been concerned that their DMTs also reduce the efficacy of COVID-19 vaccines. According to this study, those DMTs, such as Ocrevus, Kesimpta, and Rituxan, do that.
September 15, 2021 News by Marisa Wexler, MS Chronic Inflammation in MS Linked to Specific Brain Cells in Study An interaction between immune cells and glia cells in the brain, mediated by the C1q complement system protein, appears to drive chronic inflammation in multiple sclerosis (MS), new research shows. Inhibiting this protein helped to resolve inflammation in mouse models of MS and in tissue cultures, its researchers found.
November 24, 2015 News by Patricia Silva, PhD MS Patients on Salt-heavy Diets Risk Inflammation Findings from two studies, recently published in theĀ Journal of Clinical Investigation, indicate that high levels of salt alter the stability of the immune system and make it more susceptible to inflammation. The studies, which were led by Dr. David Hafler from Yale University and Dr. Dominik…